Canadian CANNAINVESTOR Magazine May 2017 - Page 54

Retail Investor's Perspective


This speculative strategy is based on the simple hypothesis that some feel it is more probable for one or more of these companies’ shares to double or more in a fraction of the time it would take for say a more established company to have its share price double or more. To date only 2.6% of the total number of applications received by Health Canada to become a License Producer have been approved. Some applicants have a higher probability to be approved while others are near zero. If those odds are outside of your risk tolerance you could consider shares in clinic networks and Canabo Medical Inc (TSXV: CMM; OTC:CAMDF) is Canada’s largest with impressive revenues and patient counts that have been increasing. Once recreational sales are legal in Canada, Loblaws (and therefore perhaps Shoppers) is not opposed to being a distributor in those provinces embracing the private sector for sales.


It is very important to understand the difference between an RTO and an IPO. Recent listings include:

Maricann Group Inc (CSE:MARI; OTC:MRRCF) - $42.5 non-dilutive financing.

AbCann Global Corporation (CSE:ABCN; OTC:ABCCF)

TerrAscend Corp (CSE:TER)

Harvest One Cannabis Inc (CSE:HVST) - HVST expansion

WeedMD Inc (CSE:WMD)

Cannabis Wheaton Income Corp (TSXV:CBW; OTC:KWFLF)